222 related articles for article (PubMed ID: 26561631)
1. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.
Aleksandrova K; Bamia C; Drogan D; Lagiou P; Trichopoulou A; Jenab M; Fedirko V; Romieu I; Bueno-de-Mesquita HB; Pischon T; Tsilidis K; Overvad K; Tjønneland A; Bouton-Ruault MC; Dossus L; Racine A; Kaaks R; Kühn T; Tsironis C; Papatesta EM; Saitakis G; Palli D; Panico S; Grioni S; Tumino R; Vineis P; Peeters PH; Weiderpass E; Lukic M; Braaten T; Quirós JR; Luján-Barroso L; Sánchez MJ; Chilarque MD; Ardanas E; Dorronsoro M; Nilsson LM; Sund M; Wallström P; Ohlsson B; Bradbury KE; Khaw KT; Wareham N; Stepien M; Duarte-Salles T; Assi N; Murphy N; Gunter MJ; Riboli E; Boeing H; Trichopoulos D
Am J Clin Nutr; 2015 Dec; 102(6):1498-508. PubMed ID: 26561631
[TBL] [Abstract][Full Text] [Related]
2. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.
Bamia C; Lagiou P; Jenab M; Trichopoulou A; Fedirko V; Aleksandrova K; Pischon T; Overvad K; Olsen A; Tjønneland A; Boutron-Ruault MC; Fagherazzi G; Racine A; Kuhn T; Boeing H; Floegel A; Benetou V; Palli D; Grioni S; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Dik VK; Bhoo-Pathy N; Uiterwaal CS; Weiderpass E; Lund E; Quirós JR; Zamora-Ros R; Molina-Montes E; Chirlaque MD; Ardanaz E; Dorronsoro M; Lindkvist B; Wallström P; Nilsson LM; Sund M; Khaw KT; Wareham N; Bradbury KE; Travis RC; Ferrari P; Duarte-Salles T; Stepien M; Gunter M; Murphy N; Riboli E; Trichopoulos D
Int J Cancer; 2015 Apr; 136(8):1899-908. PubMed ID: 25219573
[TBL] [Abstract][Full Text] [Related]
3. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
Inoue M; Yoshimi I; Sobue T; Tsugane S;
J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
[TBL] [Abstract][Full Text] [Related]
4. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
[TBL] [Abstract][Full Text] [Related]
5. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
[TBL] [Abstract][Full Text] [Related]
6. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.
Assi N; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen HC; Sundkvist A; Kühn T; Travis RC; Overvad K; Riboli E; Gunter MJ; Scalbert A; Jenab M; Ferrari P; Viallon V
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):531-540. PubMed ID: 29563134
[No Abstract] [Full Text] [Related]
7. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
Aleksandrova K; Boeing H; Nöthlings U; Jenab M; Fedirko V; Kaaks R; Lukanova A; Trichopoulou A; Trichopoulos D; Boffetta P; Trepo E; Westhpal S; Duarte-Salles T; Stepien M; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Dossus L; Racine A; Lagiou P; Bamia C; Benetou V; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita B; Peeters PH; Gram IT; Lund E; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Gavrila D; Barricarte A; Dorronsoro M; Ohlsson B; Lindkvist B; Johansson A; Sund M; Khaw KT; Wareham N; Travis RC; Riboli E; Pischon T
Hepatology; 2014 Sep; 60(3):858-71. PubMed ID: 24443059
[TBL] [Abstract][Full Text] [Related]
8. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC).
Fedirko V; Trichopolou A; Bamia C; Duarte-Salles T; Trepo E; Aleksandrova K; Nöthlings U; Lukanova A; Lagiou P; Boffetta P; Trichopoulos D; Katzke VA; Overvad K; Tjønneland A; Hansen L; Boutron-Ruault MC; Fagherazzi G; Bastide N; Panico S; Grioni S; Vineis P; Palli D; Tumino R; Bueno-de-Mesquita HB; Peeters PH; Skeie G; Engeset D; Parr CL; Jakszyn P; Sánchez MJ; Barricarte A; Amiano P; Chirlaque M; Quirós JR; Sund M; Werner M; Sonestedt E; Ericson U; Key TJ; Khaw KT; Ferrari P; Romieu I; Riboli E; Jenab M
Ann Oncol; 2013 Aug; 24(8):2166-73. PubMed ID: 23670094
[TBL] [Abstract][Full Text] [Related]
9. Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort.
Duarte-Salles T; Fedirko V; Stepien M; Aleksandrova K; Bamia C; Lagiou P; Laursen AS; Hansen L; Overvad K; Tjønneland A; Boutron-Ruault MC; Fagherazzi G; His M; Boeing H; Katzke V; Kühn T; Trichopoulou A; Valanou E; Kritikou M; Masala G; Panico S; Sieri S; Ricceri F; Tumino R; Bueno-de-Mesquita HB; Peeters PH; Hjartåker A; Skeie G; Weiderpass E; Ardanaz E; Bonet C; Chirlaque MD; Dorronsoro M; Quirós JR; Johansson I; Ohlsson B; Sjöberg K; Wennberg M; Khaw KT; Travis RC; Wareham N; Ferrari P; Freisling H; Romieu I; Cross AJ; Gunter M; Lu Y; Jenab M
Int J Cancer; 2015 Dec; 137(11):2715-28. PubMed ID: 26081477
[TBL] [Abstract][Full Text] [Related]
10. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.
Montella M; Polesel J; La Vecchia C; Dal Maso L; Crispo A; Crovatto M; Casarin P; Izzo F; Tommasi LG; Talamini R; Franceschi S
Int J Cancer; 2007 Apr; 120(7):1555-9. PubMed ID: 17205531
[TBL] [Abstract][Full Text] [Related]
11. Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort.
Assi N; Gunter MJ; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen H; Sundkvist A; Kühn T; Travis R; Overvad K; Riboli E; Scalbert A; Jenab M; Viallon V; Ferrari P
Am J Clin Nutr; 2018 Jul; 108(1):117-126. PubMed ID: 29924298
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.
Fedirko V; Duarte-Salles T; Bamia C; Trichopoulou A; Aleksandrova K; Trichopoulos D; Trepo E; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Kvaskoff M; Kühn T; Lukanova A; Boeing H; Buijsse B; Klinaki E; Tsimakidi C; Naccarati A; Tagliabue G; Panico S; Tumino R; Palli D; Bueno-de-Mesquita HB; Siersema PD; Peters PH; Lund E; Brustad M; Olsen KS; Weiderpass E; Zamora-Ros R; Sánchez MJ; Ardanaz E; Amiano P; Navarro C; Quirós JR; Werner M; Sund M; Lindkvist B; Malm J; Travis RC; Khaw KT; Stepien M; Scalbert A; Romieu I; Lagiou P; Riboli E; Jenab M
Hepatology; 2014 Oct; 60(4):1222-30. PubMed ID: 24644045
[TBL] [Abstract][Full Text] [Related]
13. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.
Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
BMJ Open; 2017 May; 7(5):e013739. PubMed ID: 28490552
[TBL] [Abstract][Full Text] [Related]
14. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
[TBL] [Abstract][Full Text] [Related]
15. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.
Setiawan VW; Wilkens LR; Lu SC; Hernandez BY; Le Marchand L; Henderson BE
Gastroenterology; 2015 Jan; 148(1):118-25; quiz e15. PubMed ID: 25305507
[TBL] [Abstract][Full Text] [Related]
16. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
[TBL] [Abstract][Full Text] [Related]
17. Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study.
Gunter MJ; Murphy N; Cross AJ; Dossus L; Dartois L; Fagherazzi G; Kaaks R; Kühn T; Boeing H; Aleksandrova K; Tjønneland A; Olsen A; Overvad K; Larsen SC; Redondo Cornejo ML; Agudo A; Sánchez Pérez MJ; Altzibar JM; Navarro C; Ardanaz E; Khaw KT; Butterworth A; Bradbury KE; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Grioni S; Vineis P; Panico S; Tumino R; Bueno-de-Mesquita B; Siersema P; Leenders M; Beulens JWJ; Uiterwaal CU; Wallström P; Nilsson LM; Landberg R; Weiderpass E; Skeie G; Braaten T; Brennan P; Licaj I; Muller DC; Sinha R; Wareham N; Riboli E
Ann Intern Med; 2017 Aug; 167(4):236-247. PubMed ID: 28693038
[TBL] [Abstract][Full Text] [Related]
18. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer.
Hu G; Tuomilehto J; Pukkala E; Hakulinen T; Antikainen R; Vartiainen E; Jousilahti P
Hepatology; 2008 Jul; 48(1):129-36. PubMed ID: 18537182
[TBL] [Abstract][Full Text] [Related]
19. Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study.
Zamora-Ros R; Fedirko V; Trichopoulou A; González CA; Bamia C; Trepo E; Nöthlings U; Duarte-Salles T; Serafini M; Bredsdorff L; Overvad K; Tjønneland A; Halkjaer J; Fagherazzi G; Perquier F; Boutron-Ruault MC; Katzke V; Lukanova A; Floegel A; Boeing H; Lagiou P; Trichopoulos D; Saieva C; Agnoli C; Mattiello A; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Engeset D; Skeie G; Argüelles MV; Molina-Montes E; Dorronsoro M; Tormo MJ; Ardanaz E; Ericson U; Sonestedt E; Sund M; Landberg R; Khaw KT; Wareham NJ; Crowe FL; Riboli E; Jenab M
Int J Cancer; 2013 Nov; 133(10):2429-43. PubMed ID: 23649669
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.
Jacobs S; Kröger J; Floegel A; Boeing H; Drogan D; Pischon T; Fritsche A; Prehn C; Adamski J; Isermann B; Weikert C; Schulze MB
Am J Clin Nutr; 2014 Sep; 100(3):891-900. PubMed ID: 25057154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
